- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
インサイト 818 results
Client Alert
2月 9, 2026
FTC’s “Landmark” Settlement with Pharmacy Benefit Manager Express Scripts: Impact on Pharma
Client Alert
2月 6, 2026
OFSI To Introduce New Enforcement Framework
Client Alert
2月 5, 2026
European Union Signs EU-Mercosur Free Trade Agreement
Client Alert
2月 3, 2026
The QMSR Goes Live and FDA Implements a New Medical Device Inspection Technique
Client Alert
Newsletter
2月 2, 2026
Health Headlines –February 2, 2026
Client Alert
2月 2, 2026
HHS-OIG Issues Guidance on Pharma DTC Prescription Drug Sales, but Key Legal Questions Remain
Client Alert
1月 30, 2026
U.S. Government Issues General License Authorizing Transactions Involving Venezuelan Oil
Client Alert
1月 27, 2026
Venezuela Business Risks and Regulations
Newsletter
1月 26, 2026
Health Headlines – January 26, 2026
Client Alert
1月 23, 2026
Firewalling the Future or Spicing Up a Known Recipe? Unpacking the New Cybersecurity Act Proposed Reform
Client Alert
1月 21, 2026
Navigating Recent Developments in the Health Information Technology Sector